Tagged with Europe

Switzerland The president of BD Europe analyses current trends and challenges in European healthcare and highlights how BD is positioning itself as a solutions provider and partner to cope with this new environment. BD acquired CareFusion in 2015 and September 30th 2016 marked the end of BD’s first full fiscal year of…

Taiwan Freddie Höglund, CEO of the European Chamber of Commerce Taiwan (ECCT), and Mike Exton, Managing Director of Novartis Taiwan and Co-Chair of the Pharmaceutical Committee of the ECCT, document the main issues at stake for the international pharmaceutical companies implanted in Taiwan, while providing us with a broader overview of…

Europe Europe accounts for 22.2 percent of global pharma sales; more than Africa, Asia, Australasia, and Latin America combined, but less than half of North America. The biopharmaceutical industry is a key contributor to the European economy in terms of both trade surplus and employment; especially highly-skilled R&D jobs. Germany is…

Asia 2016 was a year of great activity for the pharma industry, with economic uncertainties, seismic political shifts in the UK and US, and cost-containment measures in several countries. Consequently, PharmaBoardroom surveyed over 400 of its executive readership over four continents to get a sense of their optimism for the industry in 2017.…

Switzerland Santen’s Head of EMEA explains why the company established their new regional headquarters in Geneva, Switzerland and highlights the three key strategic pillars on which he bases the growth strategy for the region.   The immense talent present here contributes to the strategic value of the EMEA region, which we…

Ireland Mary Harney, Chairperson of the European Steering Group (ESG) on Sustainable Healthcare, outlines the mandate and activities of the Group, the financial tsunami that European healthcare systems face and the fundamental challenges behind building a new sustainable healthcare system; and exhorts all stakeholders to get involved. Mary, you chair the…

Switzerland The Chairman of Ferring’s Group Operating Committee and Senior Vice President Europe-Canada elaborates on how Europe can be the thinking engine for global pharmaceutical trends.   Ferring has bundled the European and Canadian markets into one single region. Could you please introduce us to the full scope of your role…

Luxembourg Sound infrastructure, a prime location in the heart of Europe, government support, and an unwavering focus on quality are all helping make the tiny principality of Luxembourg a serious player in global healthcare logistics. “Some high ranked senior logistics executives from pharma companies have commented that [the Luxair Cargo Healthcare &…

Health This chart shows the varying levels of health literacy in Europe. Health literacy is a serious issue in Hungary where 19% of the population have ‘inadequate’ knowledge and 33% are rated as ‘problematic.’ Click here to read more articles and interviews from Hungary

Pharma The founder and CEO of OAKS Consulting Czech Republic reviews his success story, starting with the change in pricing and reimbursement legislation in 2007, and explains what is needed to gain market access today. Furthermore, he describes the Czech regulatory system as transparent, predictable, and fair—if managed correctly. You founded…

Pharma The country manager of Pfizer Czech Republic reviews the advantages of Pfizer’s highly differentiated pipeline and points out how it will impact the success of the Czech affiliate in the future. Furthermore, he describes how he plans to position Pfizer as partner to the relevant stakeholders in order to utilize…

Pharma Hungary’s Minister of Foreign Affairs and Trade Péter Szijjártó highlights the significant role that foreign direct investments have played in developing the country’s healthcare and life science sector, while detailing the nation’s ambitions of not only pivoting into Europe’s hub for production, but also innovation. With over a century-long tradition,…